196 related articles for article (PubMed ID: 32258881)
21. In-Vitro Characterization and Oral Bioavailability of Organic Solvent-free Solid Dispersions Containing Telmisartan.
Cao Y; Shi LL; Cao QR; Yang M; Cui JH
Iran J Pharm Res; 2016; 15(2):385-94. PubMed ID: 27642309
[TBL] [Abstract][Full Text] [Related]
22. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
[TBL] [Abstract][Full Text] [Related]
23. Acyclovir-Polyethylene Glycol 6000 Binary Dispersions: Mechanistic Insights.
Venkateskumar K; Parasuraman S; Gunasunderi R; Sureshkumar K; Nayak MM; Shah SAA; Khoo K; Kai HW
AAPS PharmSciTech; 2017 Aug; 18(6):2085-2094. PubMed ID: 28004342
[TBL] [Abstract][Full Text] [Related]
24. Characterization and solubility study of norfloxacin-polyethylene glycol, polyvinylpyrrolidone and carbopol 974p solid dispersions.
Gorajana A; Kit WW; Dua K
Recent Pat Drug Deliv Formul; 2015; 9(2):167-82. PubMed ID: 25714525
[TBL] [Abstract][Full Text] [Related]
25. Preparation, characterization and in vivo evaluation of antihyperglycemic activity of microwave generated repaglinide solid dispersion.
Zawar LR; Bari SB
Chem Pharm Bull (Tokyo); 2012; 60(4):482-7. PubMed ID: 22466731
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000.
Liu C; Liu C; Desai KG
Drug Dev Ind Pharm; 2005 Jan; 31(1):1-10. PubMed ID: 15704852
[TBL] [Abstract][Full Text] [Related]
27. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
[TBL] [Abstract][Full Text] [Related]
28. Solid Dispersion Approach Improving Dissolution Rate of Stiripentol: a Novel Antiepileptic Drug.
Afifi S
Iran J Pharm Res; 2015; 14(4):1001-14. PubMed ID: 26664367
[TBL] [Abstract][Full Text] [Related]
29. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
30. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
31. The preparation and physicochemical characterization of eprosartan mesylate-laden polymeric ternary solid dispersions for enhanced solubility and dissolution rate of the drug.
Yousaf AM; Zulfiqar S; Shahzad Y; Hussain T; Mahmood T; Jamshaid M
Polim Med; 2018; 48(2):69-75. PubMed ID: 30916494
[TBL] [Abstract][Full Text] [Related]
32. Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers.
Xu WJ; Xie HJ; Cao QR; Shi LL; Cao Y; Zhu XY; Cui JH
Drug Deliv; 2016; 23(1):41-8. PubMed ID: 24735247
[TBL] [Abstract][Full Text] [Related]
33. Solid Dispersion of Kaempferol: Formulation Development, Characterization, and Oral Bioavailability Assessment.
Colombo M; de Lima Melchiades G; Michels LR; Figueiró F; Bassani VL; Teixeira HF; Koester LS
AAPS PharmSciTech; 2019 Feb; 20(3):106. PubMed ID: 30746582
[TBL] [Abstract][Full Text] [Related]
34. Development of a Ternary Solid Dispersion Formulation of LW6 to Improve the In Vivo Activity as a BCRP Inhibitor: Preparation and In Vitro/In Vivo Characterization.
Bajracharya R; Lee SH; Song JG; Kim M; Lee K; Han HK
Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31052438
[TBL] [Abstract][Full Text] [Related]
35. Solid dispersion of dutasteride using the solvent evaporation method: Approaches to improve dissolution rate and oral bioavailability in rats.
Choi JS; Lee SE; Jang WS; Byeon JC; Park JS
Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():387-396. PubMed ID: 29853105
[TBL] [Abstract][Full Text] [Related]
36. Formulation and in vivo hypoglycemic effect of glipizide solid dispersion.
Patel GC; Asodaria KV; Patel HP; Shah DR
Curr Drug Deliv; 2012 Jul; 9(4):395-404. PubMed ID: 22640037
[TBL] [Abstract][Full Text] [Related]
37. Study of Gliclazide Solid Dispersion Systems Using PVP K-30 and PEG 6000 by Solvent Method.
Febriyenti F; Rahmi S; Halim A
J Pharm Bioallied Sci; 2019; 11(3):262-267. PubMed ID: 31555033
[TBL] [Abstract][Full Text] [Related]
38. Development of solid dispersion systems of dapivirine to enhance its solubility.
Gorajana A; Ying CC; Shuang Y; Fong P; Tan Z; Gupta J; Talekar M; Sharma M; Garg S
Curr Drug Deliv; 2013 Jun; 10(3):309-16. PubMed ID: 23360246
[TBL] [Abstract][Full Text] [Related]
39. Physicochemical characterization and dissolution study of solid dispersions of ketoconazole with nicotinamide.
Aggarwal AK; Jain S
Chem Pharm Bull (Tokyo); 2011; 59(5):629-38. PubMed ID: 21532202
[TBL] [Abstract][Full Text] [Related]
40. Development of a binary carrier system consisting polyethylene glycol 4000 - ethyl cellulose for ibuprofen solid dispersion.
Alagdar GSA; Oo MK; Sengupta P; Mandal UK; Jaffri JM; Chatterjee B
Int J Pharm Investig; 2017; 7(3):142-148. PubMed ID: 29184827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]